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Introduction: Osteoarthritis (OA) is one of the ten most disabling diseases in developed
countries and one of the leading causes of pain and disability over the world. Early diagnosis
increases the likelihood of preventing disease progression.
Objectives: To estimate the prevalence of self-reported osteoarthritis and quality of life in
Portuguese adults with 45 or more years old.
Methods: Observational, cross-sectional study, implemented in households by face-to-face
interview.
Results: 1039 subjects with mean age of 62 years and 54.2% female were included. The preva-
lence of self-reported osteoarthritis was 9.9%. Knees and hands were the most frequent site
of  disease. The prevalence of OA was higher in women and in participants without profes-
sional activity. Presence of OA was higher in participants with comorbidities. Most subjects
have  done some treatment at some point in time for this disease: 94.5% had drug ther-
apy, 49.5% physiotherapy, and 19.8% physical activity. Pain was associated with height, with
some disease locations speciﬁcally neck, lower spine and shoulders, SF12 scores of quality
of  life, and measurements of impact in daily living, severity of disease and disability. The
impact of OA in daily living was greater in subjects that had been on sick leave or stopped
working due to OA, had worse physical and mental health, and with more  severe of disease.
Conclusion: This study conﬁrmed that osteoarthritis is a very relevant disease with a high
potential impact on quality of life, function and work ability and because of its prevalencewith  a very high growing social impact.
© 2014 Elsevier Editora Ltda. All rights reserved.∗ Corresponding author.
E-mail: luis.miranda@ipr.pt (L. Cunha-Miranda).
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Avaliac¸ão  da  magnitude  da  desvantagem  da  osteoartrite  na  vida  das
pessoas:  estudo  MOVES
Palavras-chave:
Osteoartrite
Qualidade de vida
Auto-relato
r  e  s  u  m  o
Introduc¸ão: A osteoartrite (OA) é uma das dez doenc¸as mais incapacitantes nos países desen-
volvidos e uma das principais causas de dor e incapacitac¸ão no mundo. O diagnóstico
precoce aumenta a probabilidade de prevenc¸ão da progressão da doenc¸a.
Objetivos: Estimar a prevalência de osteoartrite auto-referida e a qualidade de vida em
adultos portugueses com 45 ou mais anos de idade.
Métodos: Estudo observacional, transversal, implementado em domicílios por entrevista
interpessoal.
Resultados: Foram incluídos no estudo 1039 indivíduos com idade média de 62 anos, sendo
54,2% do gênero feminino. A prevalência de osteoartrite auto-referida foi de 9,9%. Os joe-
lhos  e as mãos foram o local mais freqüente da doenc¸a. A prevalência de OA foi maior em
mulheres e em participantes sem atividade proﬁssional. A presenc¸a de OA foi maior em
participantes com comorbidades. A maioria dos indivíduos já tinham passado por algum
tratamento em alguma ocasião de suas vidas para esta doenc¸a: 94,5% tiveram tratamento
farmacológico, 49,5% ﬁsioterapia, e 19,8% atividade física. A dor estava associada com a
estatura, com alguns locais da doenc¸a, especiﬁcamente pescoc¸o, coluna lombar e ombros,
pontuac¸ão  do SF12 para qualidade de vida, e medidas de impacto no cotidiano dos partic-
ipantes, gravidade da doenc¸a e incapacitac¸ão. O impacto da OA no dia-a-dia foi maior em
indivíduos que tinham gozado licenc¸a por doenc¸a ou que pararam de trabalhar por causa da
OA,  apresentavam-se com pior saúde física e mental, e exibiam maior gravidade da doenc¸a.
Conclusão: Este estudo conﬁrmou que a osteoartrite é uma doenc¸a muito relevante, com
impacto potencial elevado na qualidade de vida, no funcionamento e na capacidade para
o  trabalho e, por causa de sua prevalência, exerce um impacto social muito elevado e cres-
cente.
© 2014 Elsevier Editora Ltda. Todos os direitos reservados.
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introduction
steoarthritis (OA) is the most important rheumatic disease,
hich affects all the components of joints, mainly the articu-
ar cartilage.1 OA is one of the ten most disabling diseases in
eveloped countries,1 and is thought to be the most prevalent
hronic joint disease.2 It is, by far, the most common form of
rthritis and one of the leading causes of pain and disability
orldwide.1,3
Pain is the main symptom of patients with OA,4 with sig-
iﬁcant impact on functional ability, causing severe disability
n activities of daily living, and being associated with con-
iderable loss in productivity and decreased quality of life.4–7
onsidered an age-related disease, it is most likely to affect
oints that have been continually stressed throughout the
ears, including knees, hips, small hand joints, and lower
pine region.1,4,8
Worldwide, it has been estimated that 9.6% of men  and
8.0% of women aged over 60 years have symptomatic
steoarthritis.1 The main risk factors associated to OA are
ge, gender (more frequent in women), obesity, metabolic or
ndocrine diseases, trauma or joint overload, and also genetic
actors.8–10 However, the importance of individual risk factors
aries, and even differs, between joint sites.8 Many lifestyle
isk factors, however, are reversible or avoidable which has
mportant implications for its prevention. Early diagnosisincreases the likelihood of preventing disease progression to
situations of greater disability.
Because patients frequently disregard pain and symptoms,
OA tends to progress almost silently. Patients should know
their disease and have a prevention plan, avoiding mecha-
nisms that may intensify progression of disease and using
pharmacological treatments that may prevent the structural
degradation of the joint.
The MOVES study aimed to estimate the prevalence of self-
reported osteoarthritis and its impact on the quality of life, in
Portuguese adults with 45 or more  years old. In this study, we
attempted to compare subjects with and without self-reported
OA in some of the parameters that may contribute to a worse
quality of life and loss of functionality.
Methods
This observational cross-sectional study took place in 17
municipalities of mainland Portugal between September 27th
and October 26th, 2011. To ensure representativity of the pop-
ulation, the sample was stratiﬁed by region (Norte, Centro,
Lisboa, Alentejo and Algarve, age and gender, according to
estimates of National Statistics Institute (Demographic Statis-
tics 2008). The study was implemented in households, with
street selection by random procedure. Questionnaires were
administered by face-to-face interview, by speciﬁcally trained
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interviewers. Subjects from the households selected were
invited to participate if they were aged >45 years and agreed
to participate in the study.
A sample size of 1039 participants was estimated to allow
the calculation of 95% conﬁdence intervals (95%CI) for self-
reported prevalence of osteoarthritis with a precision error of
1.8%.
Collected data included, for all responders, sociode-
mographic variables, professional activity and working
conditions, comorbidities, and self-reported aspects of the
disease. For subjects reporting OA, speciﬁc data was further
collected, including OA characterization (date of diagnosis,
symptoms, site of disease), working abilities and sick leave,
treatment and therapeutic characterization, and quality of
life and functionality (SF-12 v2.0). Additionally, subjects were
asked to answer to ﬁve visual analog scales (VAS) to measure
pain intensity, impact of OA in daily living, severity of disease,
disability level and patient’s perception of the importance that
the doctor gives to the disease.
Statistical  analysis
Self-reported osteoarthritis prevalence estimates were calcu-
lated for the Portuguese population, stratiﬁed by region, age
and gender. Results were subdivided in two groups, subjects
with self-reported OA and subjects without self-reported OA.
The scores of SF-12 v2.0 were obtained with Health Outcomes
Scoring Software 4.5 and range between 0 and 100 (higher values
indicate better quality of life/health status).
Chi-square (CS) and Fisher exact tests (FS), for small
cell counts, were used to identify associations between
osteoarthritis and qualitative variables. The non-parametric
test of Mann–Whitney U was used to compare partic-
ipants with and without osteoarthritis and quantitative
variables, since the assumption of normality was not
accepted (Kolmogorov–Smirnov). Association between quan-
titative variables was conﬁrmed with Spearman correlation
coefﬁcient. Multiple logistic regression analysis results for
the presence of self-reported OA are presented by odds ratio
(OR) and 95% conﬁdence intervals. All tests were two-sided
considering a signiﬁcance level of 5%. Statistical analyses were
carried out using IBM® SPSS® Statistics 18.
This observational study was registered in ClinicalTri-
als.gov, under the number NCT01423097.
Results
This study included 1039 participants with average age of 62
years (45–99 years old) and 54.2% female. Table 1 summarizes
the sociodemographic and anthropometric characteristics of
the total sample and by group (with or without OA).
Overall, approximately 72% of the sample lived with spouse
and/or children. Overweight was observed in almost half of
the subjects (47.0%), and obesity was present in 18.0%. 65% of
participants did not have professional activity, most of them
(76.2%) by retirement, not due to OA. The mean age of onset
of labor was 15.2 years (SD = 5.7). 2 0 1 5;5 5(1):22–30
Hypertension was the most frequent comorbidity (32.2%),
followed by diabetes (15.4%) and cardiovascular disorders
(14.2%). Approximately 30% of participants reported no illness.
The prevalence of self-reported osteoarthritis, in this study,
was 9.9% (95% CI: 8.1–11.7%).
The prevalence of OA was higher in women (13.3% ver-
sus 5.9%; p < 0.001), in subjects from Norte and in participants
without professional activity, as shown in Table 1. The partici-
pants with OA were older (median age = 64) and had less years
of education.
For the overall sample, the self-reported prevalence of OA
was 6.3% in the knees, and 5.5% and 3.1% in hands and feet,
respectively. Spine had a prevalence of 2.7%, and ankles and
hips, 2.2%. Fists, shoulders, elbows, neck and thoracic spine
all had prevalence’s under 2%.
Presence of OA was higher in participants with comorbidi-
ties (13.5% versus 1.6% without; p < 0.001). Subjects with OA
presented higher median number of comorbidities (2 versus 1
in subjects without OA; p < 0.001).
The prevalence of OA was associated with some of
the comorbidities: rheumatoid arthritis, depression, kidney
problems, intestinal disorders, osteoporosis, cardiovascular
disorders, diabetes and hypertension (Fig. 1).
The results of multiple logistic regressions for the presence
of self-reported osteoarthritis (Table 2) showed that the risk of
OA is 2 times higher for women, 2.6 times higher for subjects
with rheumatoid arthritis, and 1.8 times higher for those with
more  comorbidities.
For the subgroup of subjects with self-reported OA, fur-
ther data was collected in order to understand which variables
could have had some impact on the disease. Table 3 summa-
rizes the evaluation variables of subjects with OA.
In this group of subjects, the average age at diagnosis was
52 years old (20–85 years), and the mean time between com-
plaint and diagnosis was 3 years, ranging from 1 month to
35 years. The mean duration of disease was 13 years (1–56
years). In most cases, the general practitioner diagnosed the
disease (63.0%) and is the one who follows the patient (58.4%).
Approximately 92% of self-reported prevalent subjects had X-
ray conﬁrmed diagnosis.
Among subjects with OA, knees and hands were the most
frequent site of disease (63.1% and 55.3% respectively), and the
thoracic spine the less frequent site registered (8.7%).
Approximately 30% of OA subjects have been on sick leave
at some moment in time or stopped working due to this con-
dition. Absenteeism ranged between 3 days and 3 years. From
these, 41.4% changed their type of work, 34.5% change the
way of working for reasons related to OA, and 10.3% stopped
working completely because of the disease.
Most of OA prevalent subjects (88.3%) have done some
treatment for this disease at some moment in time: 94.5% had
drug therapy, 49.5% physiotherapy, and 19.8% physical activ-
ity; surgery and special diet were also referred. Approximately
84% of patients took NSAIDs to treat OA (42.0% used only
NSAIDs), 46.9% took analgesics (3.7% used only analgesics),
and 34.6% were on disease modifying drugs (6.2% used only
disease modifying drugs) (Table 3).Most of the subjects reported the intake of analgesics
(52.4%) or anti-inﬂammatory drugs (86.9%) in the 3 months
previous to the study. On average, intake of analgesics
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Table 1 – Sample characteristics.
Total (n = 1039) Without self-reported OA (n = 936) With self-reported OA (n = 103) p-value
Age (years) 62.0 (45–99) 61.0 (45–99) 64.0 (45–87) MW:0.002
Gender†
Female 563 54.2% 488 86.7% 75 13.3% CS:<0.001
Male 476 45.8% 448 94.1% 28 5.9%
Region†
Norte 355 34.2% 309 87.0% 46 13.0% CS:0.036
Centro 262 25.2% 243 92.7% 19 7.3%
Lisboa 284 27.3% 253 89.1% 31 10.9%
Alentejo 94 9.0% 88 93.6% 6 6.4%
Algarve 44 4.2% 43 97.7% 1 2.3%
Scholarship (years) 5.0  (0–26) 6.0 (0–26) 4.0 (0–19) MW:0.020
Living with†
Alone 183 17.6% 166 90.7% 17 9.3% NA
With family/friends 105 10.1% 101 96.2% 4 3.8%
Spouse/children 749 72.2% 667 89.1% 82  10.9%
Retirement home 1 0.1% 1 100.0% 0 0.0%
BMI (kg/m2)†  22.2 (15.2–42.2) 26.2 (15.2–42.2) 26.7 (16.9–40.1) MW:0.068
Underweight 6 0.6% 5 83.3% 1 16.7% CS:0.213
Normal weight 356 34.4% 329 92.4% 27 7.6%
Overweight 486 47.0% 435 89.5% 51 10.5%
Obesity 186 18.0% 162 87.1% 24 12.9%
Professional activity† 369  35.5% 342 92.7% 27  7.3% CS:0.038
Comorbidities†
Hypertension 334 32.2% 289 30.9% 45 43.7% CS:0.008
Cardiovascular disorders 147 14.2% 121 12.9% 26 25.2% CS:0.001
Diabetes 160 15.4% 137 14.7% 23 22.3% CS:0.041
Osteoporosis 100 9.6% 80 8.6% 20 19.4% CS:<0.001
Depression 87 8.4% 67 7.2% 20 19.4% CS:<0.001
Kidney problems 51 4.9% 40 4.3% 11 10.7% CS:0.004
Intestinal disorders 43 4.1% 34 3.6% 9 8.7% FS: 0.031
Rheumatoid arthritis 25 2.4% 16 1.7% 9  8.7% FS:<0.001
Lung problems 29 2.8% 23 2.5% 6 5.8% FS:0.059
Cancer 52 5.0% 47 5.0% 5 4.9% CS:0.939
Liver problems 16 1.5% 12 1.3% 4 3.9% FS:0.065
Gastric ulcer 19 1.8% 17 1.8% 2 1.9% FS:>0.999
Fibromyalgia 5 0.5% 4 0.4% 1 1.0% FS:0.408
Other 197 19.0% 163 17.4% 34 33.0% –
No. of comorbidities 1.0  (0–8) 1.1  (0–6) 2.1(0–8) MW:<0.001
MW, Mann–Whitney; CS, Chi-square; FS, Fisher exact test; NA, Not applicable.
Values presented in median (minimum–maximum) except in categorical variables (†),  presented n (%).
For comorbidities, the percentages were calculated within groups (with and without self-reported OA).
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Rheumatoid arthritis**
Liver problems
Depression*
Kidney problems*
Intestinal disorders**
Lung problems
Osteoporosis*
Fibromyalgia
Cardiovascular disorders*
Diabetes*
Hypertension*
Gastric ulcer
Cancer
5%0% 10% 15% 20% 25% 30% 35% 40%
No
Yes
% participants with self-reported osteoarthritis
* p < 0.050, Chi-square test.
** p < 0.050, Fisher exact test.
Fig. 1 – Association between comorbidities and osteoarthritis.
Table 2 – Logistic regression for the presence of
self-reported osteoarthritis.
OR 95% CI for OR
Gender
Male Ref.
Female 2.017 [1.263;3.223]
Rheumatoid arthritis
No Ref.
Yes 2.585 [1.027; 6.506]
No. of comorbidities 1.780 [1.499; 2.113]
Ref.: Category versus the one is making comparisons.
This study uses self-reported information, which has some
limitations, once it did not require medical conﬁrmation ofoccurred 4 days/week (1–7 days per week) during 6 weeks. The
intake of anti-inﬂammatory drugs occurred on average for 5
days/week during 7 weeks.
Results from VAS evaluation are shown in Table 3. On aver-
age, pain intensity adds up to 4.5 points while severity of
disease adds up to 5.9 points, considering a mean disability
level of 5.3. Impact on daily living scores 6.1 points on VAS,
being the most important parameter associated to this disease
from the patient’s perspective. Subject’s perception of doctor’s
importance to disease is scored with 6.4 points.
Analysis of SF-12 v2.0 demonstrated that overall score for
mental health registered a higher value than overall score for
physical health, suggesting that patients have a better quality
of mental life than physical (45.9 points [SD = 12.7] and 38.5
points [SD = 9.3], respectively) (Fig. 2).
Association tests have been done to understand which
variables relate to pain in OA. In the present study, pain was
associated with stature (rs = −0.221; p = 0.025) and some sites
of disease [neck (7.9 versus 4.2 points in OA of other sites;
p = 0.008); hands (5.0 versus 3.1 points in OA of other sites;
p = 0.029); spine (7.3 versus 4.1 points in OA in other sites;
p = 0.020); and shoulders (7.2 versus 4.1 points in OA in other
sites; p = 0.025)]. Pain was also associated with SF12 scores
of quality of life (physical health: rs = −0.479; p < 0.001 and
mental health: rs = −0.414; p < 0.001), and VAS measurements
of impact of OA in daily living (rs = 0.524; p < 0.001), severityof disease (rs = 0.557; p < 0.001) and disability level (rs = 0.587;
p < 0001).
Furthermore, we evaluated the parameters to which the
impact of OA in daily living (VAS) was related. Statistically
higher scores for the impact of OA in daily living were shown
by subjects that had been on sick leave or stopped working
due to OA (8.1 points versus 6.0 points; p = 0.001). In addition,
a higher impact of OA on daily living was associated with
worse physical health (rs = −0.582; p < 0.001), mental health
(rs = −0.460; p < 0.001), and with higher severity of disease
(rs = 0.506; p < 0.001).
Discussion
This epidemiological study aimed to evaluate osteoarthritis in
adult individuals over 45 years of age in Portugal. The results
suggest that the prevalence of self-reported OA in the Por-
tuguese population with 45 or more  years of age is between
8.1% and 11.7%. This result is similar to the prevalence results
reported in countries like Canada, United States, UK,  Australia,
New Zealand, Belgium, and the Netherlands.11,12 The overall
prevalence of OA among Norwegian inhabitants was 12.8%,
being signiﬁcantly higher among women than men.13,14 In
Dutch population with OA, the prevalence of knee osteoarthri-
tis was higher than hip one, which is also reported in other
countries,12,14 as well as in our study in Portugal.15 In Poland,
OA was diagnosed in 14.7% of participants. The occurrence
of OA increased with age, being highest in the group aged
more  than 50 years, and more  frequent in women.14 Spain
has shown an estimated prevalence of symptomatic knee OA
of 10.2% in general adult population over 20 years old, and
6.2% for symptomatic hand OA. These results were mainly
related to a high rate of knee pain in women aged more  than
55 years.14,16–18
However, most of the published studies11,13–15 report preva-
lence data from knees, hands and hip symptomatic OA.
Information about other sites of disease is very scarce.the diagnosis. As such, it is possible that some subjects report
as diagnosed when they were not, and, on the contrary, some
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Table 3 – Characterization of subjects with OA.
With self-reported OA (n = 103)
Age at diagnosis,  years (SD)  52.3 (12.0)
Time from complaint to diagnosis,  years (SD) 2.9 (4.8)
Duration of disease, years (SD) 12.7 (10.4)
Site of disease N %
Knees 65 63.1%
Hands 57 55.3%
Feet 32 31.1%
Lumbar spine 28  27.2%
Hips 23 22.3%
Ankles 23 22.3%
Fists 20 19.4%
Shoulders 19 18.4%
Elbows 16 15.5%
Neck 12 11.7%
Thoracic spine 9 8.7%
Working abilities and sick leave (last year)  N %
Changed the type of work due to OA 12 41.4%
Changed the way of working due to OA 10 34.5%
Reduced nr. of working hours due to OA 1 3.4%
Did not work some days due to OA 2  6.9%
Stopped working completely due to OA 3  10.3%
Other 1 3.4%
Have done any treatment (ever) for OA 91 88.3%
Drug therapy 86 94.5%
Physiotherapy 45 49.5%
Physical activity 18 19.8%
Surgery 9 9.9%
Special diet 1 1.1%
Other 7 7.7%
Drug therapy for OA over the last 3 months N %
NSAIDs 34 42.0%
NSAIDs + Analgesics 16 19.8%
NSAIDs + Analgesics + Disease modifying 14 17.3%
Disease modifying 5 6.2%
Analgesics + Disease modifying 5 6.2%
NSAIDs + Disease modifying 4 4.9%
Analgesics 3 3.7%
Total 81 100.0%
Visual Analog Scales – VAS (SD)
Pain intensity 4.5 (3.3)
Impact of OA in daily living 6.1 (2.8)
Severity of disease 5.9 (2.4)
Disability level 5.3 (2.7)
Subject’s perception of doctor’s importance to disease 6.4 (3.0)
Values presented in mean (SD) except in categorical variables (†),  presented n (%).
0 605040302010
Vitality
Social function
Mental health
Role physical
Pain
Role emotional
Physical function
Mental health summary
Physical health summary
Worst state Best stateMean
General health
Fig. 2 – Scores of quality of life and functionality (SF-12 v2.0).
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might think they have been diagnosed with another condition
but were diagnosed with OA, implying a risk of false-positive or
false-negative diagnosis. In summary, assessment of disease
through self-report information can lead to some misdiag-
noses, nevertheless self-reported information is considered
an important indicator of a person’s condition, even though
it is dependent on how one perceives and acknowledges his
or her disease.
Not surprisingly, in our study the most common sites for OA
were also knees and hands. However, despite high evidence
of hip OA reported in other countries,13,19–21 this has not been
demonstrated in this population.
Age, gender, obesity, injuries, occupation and physical
activity are some of the risk factors associated with OA
that have been extensively discussed previously on published
literature.14,22–24
The oxidative damage that occurs with age is one of
the main responsible for the development of OA. Women
are more  likely to have OA than men  and also to develop
more severe forms of disease. The results from this study
conﬁrm these ﬁndings with prevalence of OA being higher
in women than in men, in line with results reported
from other countries.11,13,16,18,25,26 Also in line with other
studies,2,11,13,16,18,25,27 age was associated with OA, with a
higher median age in subjects with OA.
Some studies have shown that risk factors for OA of dif-
ferent localization may vary. In Italy, hip OA results showed
correlations with weight, genetic factors, gender, previous
traumas, occupational factors, and age, while knee OA had
great correlation with weight, lifestyle, and physical activity.14
Obesity and overweight have long been recognized a potent
risk factor for OA, especially OA of the knee.2,7,22,27 Also, BMI
appears to play important roles in determining disability of
individuals.28 In the present study, however, OA was not asso-
ciated with BMI, as opposed to data from a population survey
in Norway,13 where BMI  was signiﬁcantly associated with hip
and knee OA.
It has been shown that, in OA patients, comorbid con-
ditions may affect not only disease progression, but also
their psychological well-being, independently of the extent of
disease.29,30 In our study, the prevalence of OA was higher in
subjects with hypertension, cardiovascular disorders and dia-
betes. These comorbidities have also been reported by other
authors, along with depression, dyslipidemia or other mus-
culoskeletal conditions.31–33 Our ﬁndings showed a risk of OA
higher for subjects with more  comorbidities which result in
an increased need for attention, investigate and treat those
comorbidities in order to try to diminish the associated dis-
ability and decrease in QoL in patients with those conditions.
Our results showed that OA was associated with less years
of education and absenteeism, which was also one of the ﬁnd-
ings from the Norwegian13 and Spanish16,18 studies, in which
an increased occurrence of OA was observed in people with
less than 12 years of education and in those out of work.
Concerning absenteeism or working conditions associated
to OA, the results of the present study were in line with
4those reported in the US, with similar percentage of sub-
jects, changing type or way of working due to OA in our
study compared to overall work and activity impairment reg-
istered in US. Employment reduction due to OA might also be 2 0 1 5;5 5(1):22–30
dependent on the site affected by OA.34 In the US study,4 work-
ers with OA pain reported signiﬁcantly lower SF-12 health
status when compared to workers without OA pain. Likewise,
we also found lower scores on physical components which,
not surprisingly, have been proved to be associated to pain,
since OA and pain affect physical functioning.4,13,30
In our study, pain measured by VAS was also associated
with impact on daily living, severity of disease and disability
level. According to literature, pain relief is the main motiva-
tor in patients with OA seeking medical attention.14 Given the
relationship between pain and quality of life, it is important
to seek proper ways to provide patient’s with better quality of
life. It is important to understand the relationship between OA,
self-reported pain and disability measures, to develop a better
knowledge of the effect that OA has on a patient’s life, progres-
sion of disease, and effective pathways for intervention.29,30
For some authors,22,30 pain and function are assumed as
symptomatic outcomes of OA that may frequently be con-
sidered by patients as part of the pharmacologic efﬁcacy
evaluation, associated with one’s perceptions of severity and
improvement. In our study, the results point out to a relation-
ship between impact on daily living, severity and disability,
which were the outcomes most considered as being associated
to this disease, from the patients’ perspective. Statistically,
neck has been the most painful site of disease for the sub-
jects in this study, which is quite uncommon in other similar
studies already published. Along with neck, also lumbar spine
and shoulders were statistically signiﬁcant for pain and over-
all these pain levels might be responsible for the results, from
the patients’ perspective for impact on daily living and disabil-
ity. Some studies5,14,28,29 reported that the presence of pain in
osteoarthritis of the hip and knees were strongly associated
with perceptions of disability in basic activities of daily living.
Associations between self-reported OA, severity and other
patient-reported outcomes indicate the clinical relevance
of asking patients to self-evaluate their condition.14 This
approach may represent an additional way to assess OA in
clinical practice, although further data is needed to conﬁrm
the utility of this method.
Conclusion
There are a few studies assessing self-reported OA and its
impact on daily life. With this study we attempted to under-
stand how patients are affected by this disease.
Our study conﬁrms that the prevalence of osteoarthritis
was higher in women and is associated with age. Among sub-
jects with OA, knees and hands were the most frequent site
of self-reported disease. OA was associated with fewer years
of education and absenteeism. Impact on daily living was
patients’ most important parameter associated to this disease,
which was also associated with worse physical and mental
health, and with higher severity of disease.
Overall, our study conﬁrms that the impact of OA  is very
signiﬁcant on patients over 45 years old and that is also
present in patients with several other diseases. That might
indicate a proﬁle of patient with lower global health status in
whom OA contributes for a diminished quality of life.
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In a growing-old population, that has to work for more
ears, OA has to be considered in terms of prevention and
reatment in order to control the global impact of the disease
ot only on patients, but also on society.
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